Showing results (221-230 of 231) with videos related to
Sort By:
Pageof 24
International Journal of Radiation Oncology, Biology, Physics|March 20, 2020
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual TreatmentsRainer J Klement, Jan-Jakob Sonke, Michael Allgäuer, et al.Neuro-Oncology|December 21, 2016
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813Susan Chang, Peixin Zhang, J Gregory Cairncross, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2017
Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937Elizabeth M Gore, Chen Hu, Alexander Y Sun, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2021
Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed GlioblastomaDavid W Andrews, Kevin D Judy, Charles B Scott, et al.Neuro-Oncology|November 5, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS LymphomaAntonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, et al.International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain MetastasesNoelle L Williams, Evan J Wuthrick, Hyun Kim, et al.The New England Journal of Medicine|February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastomaMark R Gilbert, James J Dignam, Terri S Armstrong, et al.International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.JAMA Oncology|June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 TrialErica H Bell, Peixin Zhang, Barbara J Fisher, et al.Pageof 24